Krueppel-like factor 7 (KLF7)

Krueppel-like factor 7 (KLF7) is a zinc finger transcription factor broadly expressed across tissues, with roles in regulating gene expression related to neuronal development, axon regeneration, adipogenesis, muscle formation, stem cell maintenance, and cellular differentiation. KLF7 controls transcription by binding to specific DNA motifs (CACCC and Sp1 sites), and regulates key genes including p21, p27, TRKA, TRKB, IL-6, C/EBPα, PPARγ, leptin, and adiponectin. In the nervous system, KLF7 is crucial for promoting axon growth and regeneration, and its activity has been engineered in vivo for spinal cord injury models. In adipose tissue, KLF7 acts as a negative regulator of adipogenesis and regulates adipocyte metabolism. Aberrant KLF7 expression has oncogenic implications in several cancers, and it is implicated in the regulation of pluripotency and differentiation of stem cells. There are currently no approved drugs targeting KLF7 directly, but its molecular and developmental functions make it a target of research in oncology, regenerative medicine, and metabolic disease contexts[1][2][3].

Other names

KLF7UKLF (ubiquitous Kruppel-like factor)Krueppel-like factor 7 (ubiquitous)Ubiquitous Kruppel-like transcription factorKLF7, Kruppel-like factor 7Ubiquitous Krueppel-like factor

Not applicable; no approved or experimental drugs targeting KLF7 directly. Experimental approaches involve genetic manipulation or chimeric proteins (VP16-KLF7) to enhance or suppress KLF7 function for neuronal regeneration or cancer[3].